A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis
Clinical trial NCT00131300 · COMPLETED
Trial details
- NCT number
- NCT00131300
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.